Ventyx Biosciences
VTYX
VTYX was delisted on the 3rd of March, 2026.
114 hedge funds and large institutions have $95.1M invested in Ventyx Biosciences in 2025 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 30 increasing their positions, 41 reducing their positions, and 34 closing their positions.
207% more call options, than puts
Call options by funds: $387K | Put options by funds: $126K
86% more capital invested
Capital invested by funds: $51.1M → $95.1M (+$44M)
0.02% more ownership
Funds ownership: 62.42% → 62.43% (+0.02%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 34
2% less funds holding
Funds holding: 116 → 114 (-2)
27% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 41
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAA
Affinity Asset Advisors
New York
|
+$7.33M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$3.87M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$2.68M |
| 4 |
Millennium Management
New York
|
+$1.9M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$1.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$4.96M |
| 2 |
SCM
Sio Capital Management
New York
|
-$2.06M |
| 3 |
State Street
Boston,
Massachusetts
|
-$1.55M |
| 4 |
Renaissance Technologies
New York
|
-$1.53M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$1.21M |
VTYX Hedge Fund Activity: Q2 2025 in Review
114 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in Ventyx Biosciences (VTYX) for Q2 2025, worth a combined $95.1M — up 86% from $51.1M a quarter earlier.
Sellers outnumbered buyers: 34 funds closed out of VTYX and 32 opened new positions — a net loss of 2 holders — while 41 trimmed existing stakes and 30 added.
The largest buyer was Affinity Asset Advisors, opening a new position worth an estimated $7.33M. The largest seller was BlackRock, cutting an estimated $4.96M.
- 114 institutional investors held Ventyx Biosciences (VTYX) as of Q2 2025, down from 116 in Q1 2025.
- Funds reported $95.1M of Ventyx Biosciences stock for Q2 2025, up 86% quarter-over-quarter.
- 32 funds opened new Ventyx Biosciences positions in Q2 2025 and 34 closed out, a net change of -2 holders.
- The largest Ventyx Biosciences buyer in Q2 2025 was Affinity Asset Advisors, an estimated $7.33M added.
- The largest Ventyx Biosciences seller in Q2 2025 was BlackRock, an estimated $4.96M sold.
Based on aggregated 13F filings for Q2 2025.